Press Release GERN Deadline: Rosen Law Firm Urges Geron Corporation (NASDAQ: GERN) Stockholders to Contact the Firm for Information About Their Rights 27 April 2025
Press Release KEYTRUDA® (pembrolizumab) as Perioperative Treatment With Standard of Care (SOC) Adjuvant Therapy Significantly Improved Event-Free Survival Compared to SOC Alone in Patients With Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma 27 April 2025
Press Release FLNC Deadline: Rosen Law Firm Urges Fluence Energy, Inc. (NASDAQ: FLNC) Stockholders to Contact the Firm for Information About Their Rights 27 April 2025
Press Release RC Deadline: Rosen Law Firm Urges Ready Capital Corporation (NYSE: RC) Stockholders to Contact the Firm for Information About Their Rights 27 April 2025
Press Release Lead Plaintiff Deadline on May 12, 2025 for GERN Investors – Kessler Topaz Meltzer & Check, LLP Encourages Investors with Losses to Contact the Firm 27 April 2025
Press Release MRVI Deadline: Rosen Law Firm Urges Maravai Lifesciences Holdings, Inc. (NASDAQ: MRVI) Stockholders to Contact the Firm for Information About Their Rights 27 April 2025
Press Release TFII Deadline: Rosen Law Firm Urges TFI International Inc. (NYSE: TFII) Stockholders to Contact the Firm for Information About Their Rights 27 April 2025
Press Release RKLB Deadline: Rosen Law Firm Urges Rocket Lab USA, Inc. (NASDAQ: RKLB) Stockholders to Contact the Firm for Information About Their Rights 27 April 2025
Press Release ELF Deadline: Rosen Law Firm Urges e.l.f. Beauty, Inc. (NYSE: ELF) Stockholders to Contact the Firm for Information About Their Rights 27 April 2025
